Bladder Tumor Heterogeneity: The Impact on Clinical Treatment

Publisher： Karger

E-ISSN： 1423-0399|95|1|1-8

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.95, Iss.1, 2015-03, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On heterogeneity of treatment effects and clinical freedom

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 1, 2015-01 ,pp. : 6-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of Bladder Tumor Markers in the Clinical Practice

By  

Current Urology, Vol. 5, Iss. 3, 2011-10 ,pp. : 113-120

Karger

Access to resources Recommend Favorite

Overactive bladder in women: symptom impact and treatment expectations

By MacDiarmid Scott   Rosenberg Matt  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1413-1422

Informa Healthcare

Access to resources Recommend Favorite

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses

By Tyson Darren R   Quaranta Vito  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 221-225

Future Medicine

Access to resources Recommend Favorite

Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma

By  

Urologia Internationalis, Vol. 87, Iss. 4, 2011-10 ,pp. : 420-428

Karger

Access to resources Recommend Favorite